A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed [National Institutes of Health]
卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类的应助被泡椒采纳,获得10
刚刚
zzy完成签到 ,获得积分10
1秒前
闯天涯完成签到,获得积分10
1秒前
preference完成签到 ,获得积分10
1秒前
2秒前
2秒前
Augreen完成签到,获得积分10
2秒前
baiyz完成签到,获得积分10
2秒前
独挚完成签到 ,获得积分10
2秒前
林齐发布了新的文献求助10
2秒前
3秒前
3秒前
Irving_0419完成签到,获得积分10
3秒前
岳晓青发布了新的文献求助20
3秒前
Owen的应助被YONGLI采纳,获得10
4秒前
飘逸谷蕊完成签到 ,获得积分10
4秒前
123完成签到,获得积分10
4秒前
不落星发布了新的文献求助10
4秒前
忧郁的灵竹完成签到,获得积分10
4秒前
4秒前
de完成签到,获得积分10
4秒前
叔白完成签到,获得积分10
5秒前
孙冲完成签到,获得积分10
5秒前
aeiou完成签到,获得积分10
5秒前
白英慧完成签到,获得积分10
5秒前
5秒前
夏弱发布了新的文献求助10
5秒前
5秒前
思源的应助被易宋采纳,获得10
5秒前
小不点完成签到,获得积分10
6秒前
飘逸香彤完成签到,获得积分20
6秒前
晚风发布了新的文献求助10
6秒前
JCY123完成签到,获得积分10
6秒前
酷波er的应助被yy采纳,获得30
7秒前
7秒前
uniphoton完成签到,获得积分10
7秒前
Farrell关注了科研通微信公众号
7秒前
Re镇魂曲完成签到,获得积分10
7秒前
ZDP发布了新的文献求助10
8秒前
沙力VAN发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Sustainable Engineered Micro/Nanofibers and Hybrid Nanocomposites for Environmental Remediation 400
Ecotourism 400
Liquidus diagram and viscosity estimation in pseudo-binary system Li2B6O10–LiF 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8076592
求助须知:如何正确求助?哪些是违规求助? 9494588
关于积分的说明 21381863
捐赠科研通 7644600
什么是DOI,文献DOI怎么找? 3400135
关于科研通互助平台的介绍 2529879
邀请新用户注册赠送积分活动 2438791